Suppr超能文献

非合胞体诱导的巨噬细胞嗜性1型人类免疫缺陷病毒对初始CD4 + T细胞的杀伤作用

Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.

作者信息

Yu X, McLane M F, Ratner L, O'Brien W, Collman R, Essex M, Lee T H

机构信息

Department of Cancer Biology, Harvard School of Public Health, Boston, MA 02115.

出版信息

Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10237-41. doi: 10.1073/pnas.91.21.10237.

Abstract

Understanding the mechanism by which human immunodeficiency virus type 1 (HIV-1) kills CD4+ T lymphocytes is important to the development of therapeutic and prophylactic strategies. Recent studies have indicated that, in some cases, progression to AIDS is associated with the appearance of syncytium-inducing, T cell line-tropic HIV-1 variants. Nevertheless, approximately 50% of subjects with AIDS harbor only non-syncytium-inducing, macrophage-tropic (NSI-M) variants of HIV-1. In most asymptomatic patients, NSI-M HIV-1 isolates are the predominant virus type found. We report here that cytopathicity of NSI-M HIV-1 for primary CD4+ T lymphocytes can be directly detected in vitro. The extent of CD4+ T-cell killing was not completely correlated with the rate of viral replication, suggesting that other characteristics of HIV-1 contribute to its cytopathicity. Our findings suggest that: (i) direct killing by NSI-M HIV-1 may contribute to CD4+ T-lymphocyte depletion in vivo, and (ii) the determinants of HIV-1 cytopathicity for CD4+ T lymphocytes and cell tropism or syncytia-forming ability are not necessarily tightly linked.

摘要

了解人类免疫缺陷病毒1型(HIV-1)杀死CD4+ T淋巴细胞的机制对于治疗和预防策略的开发至关重要。最近的研究表明,在某些情况下,进展为艾滋病与诱导合胞体形成的、嗜T细胞系的HIV-1变体的出现有关。然而,约50%的艾滋病患者仅携带非诱导合胞体形成的、嗜巨噬细胞的(NSI-M)HIV-1变体。在大多数无症状患者中,NSI-M HIV-1分离株是发现的主要病毒类型。我们在此报告,NSI-M HIV-1对原代CD4+ T淋巴细胞的细胞病变效应可在体外直接检测到。CD4+ T细胞杀伤程度与病毒复制速率并不完全相关,这表明HIV-1的其他特性也有助于其细胞病变效应。我们的研究结果表明:(i)NSI-M HIV-1的直接杀伤作用可能导致体内CD4+ T淋巴细胞耗竭,以及(ii)HIV-1对CD4+ T淋巴细胞的细胞病变效应决定因素与细胞嗜性或形成合胞体的能力不一定紧密相关。

相似文献

引用本文的文献

1
Quasispecies Nature of RNA Viruses: Lessons from the Past.RNA病毒的准种特性:历史教训
Vaccines (Basel). 2023 Jan 30;11(2):308. doi: 10.3390/vaccines11020308.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验